KYMR
Kymera Therapeutics Inc
NASDAQ: KYMR · HEALTHCARE · BIOTECHNOLOGY
$81.51
-2.79% today
Updated 2026-04-29
Market cap
$6.65B
P/E ratio
—
P/S ratio
169.71x
EPS (TTM)
$-3.69
Dividend yield
—
52W range
$28 – $103
Volume
0.7M
Kymera Therapeutics Inc (KYMR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,411.00%
ROE
-25.80%
ROA
-15.90%
Debt/equity
0.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-21.47M | — | — | — |
| 2019 | $2.93M | $-41.29M | 71.88% | -1,438.48% | -1,407.36% |
| 2020 | $34.03M | $-45.59M | 100.00% | -136.05% | -133.96% |
| 2021 | $72.83M | $-100.22M | 100.00% | -138.03% | -137.60% |
| 2022 | $46.83M | $-154.81M | 100.00% | -344.37% | -330.60% |
| 2023 | $78.59M | $-146.96M | 100.00% | -210.62% | -186.99% |
| 2024 | $47.07M | $-223.86M | 100.00% | -555.82% | -475.57% |
| 2025 | $39.20M | $-311.40M | 100.00% | -891.33% | -794.39% |